[HTML][HTML] Glypican-3 induces a mesenchymal to epithelial transition in human breast cancer cells

LF Castillo, R Tascón, MAL Huvelle, G Novack… - Oncotarget, 2016 - ncbi.nlm.nih.gov
Breast cancer is the disease with the highest impact on global health, being metastasis the
main cause of death. To metastasize, carcinoma cells must reactivate a latent program …

[HTML][HTML] Downregulation of glypican-4 facilitates breast cancer progression by inducing cell migration and proliferation

J Munir, T Van Ngu, PDN Ayudthaya, S Ryu - Biochemical and Biophysical …, 2020 - Elsevier
Abstract Glypican-4 (GPC-4) is a heparan sulphate glycoprotein, associated with cell
membrane via a Glycosyl phosphatidyl (GPI)-anchor. It is involved in cell migration, cell …

Glypican-3 regulates migration, adhesion and actin cytoskeleton organization in mammary tumor cells through Wnt signaling modulation

I Stigliano, L Puricelli, J Filmus, MC Sogayar… - Breast cancer research …, 2009 - Springer
Abstract Glypican-3 (GPC3) is a proteoglycan involved in migration, proliferation and cell
survival modulation in several tissues. There are many reports demonstrating a …

[HTML][HTML] Downregulation of GLYAT facilitates tumor growth and metastasis and poor clinical outcomes through the PI3K/AKT/snail pathway in human breast cancer

X Tian, L Wu, M Jiang, Z Zhang, R Wu, J Miao… - Frontiers in …, 2021 - frontiersin.org
Background The Glycine N-acyltransferase (GLYAT) gene encodes a protein that catalyzes
the transfer of acyl groups from acyl CoA to glycine, resulting in acyl glycine and coenzyme …

Glypican-1 overexpression in different types of breast cancers

FOFO Alshammari, YM Al-Saraireh… - OncoTargets and …, 2021 - Taylor & Francis
Purpose Treatment of metastatic breast cancer patients is challenging and remains a major
underlying cause of female mortality. Understanding molecular alterations in tumor …

Glypican-3 reexpression regulates apoptosis in murine adenocarcinoma mammary cells modulating PI3K/Akt and p38MAPK signaling pathways

C Buchanan, I Stigliano, HM Garay-Malpartida… - Breast cancer research …, 2010 - Springer
Abstract Glypican-3 (GPC3) is a proteoglycan involved in proliferation and cell survival.
Several reports demonstrated that GPC3 is downregulated in some tumors, such as breast …

Inhibition of invasion and metastasis by glypican-3 in a syngeneic breast cancer model

MG Peters, E Farias, L Colombo, J Filmus… - Breast cancer research …, 2003 - Springer
Abstract Glypican-3 (GPC3), a proteoglycan bound to the cell membrane through a GPI
anchor, is widely expressed in the embryo but down regulated in most adult tissues, with …

[HTML][HTML] Glypican-3 induces oncogenicity by preventing IGF-1R degradation, a process that can be blocked by Grb10

W Cheng, PC Huang, HM Chao, YM Jeng, HC Hsu… - Oncotarget, 2017 - ncbi.nlm.nih.gov
Hepatocellular carcinoma (HCC) is the most common primary liver malignancy and is a
major cause of cancer-related death worldwide. Previously, we demonstrated that glypican …

Glypican-3-mediated oncogenesis involves the Insulin-like growth factor-signaling pathway

W Cheng, CJ Tseng, TTC Lin, I Cheng, HW Pan… - …, 2008 - academic.oup.com
Abstract Glypican-3 (gpc3) is the gene responsible for Simpson-Golabi-Behmel overgrowth
syndrome. Previously, we have shown that GPC3 is overexpressed in hepatocellular …

[HTML][HTML] Glypican-3 promotes epithelial-mesenchymal transition of hepatocellular carcinoma cells through ERK signaling pathway

Y Wu, H Liu, H Weng, X Zhang… - International …, 2015 - spandidos-publications.com
Abstract Glypican-3 (GPC3), a membrane-associated heparan sulfate proteoglycan, is
frequently upregulated in hepatocellular carcinoma (HCC). However, how GPC3 contributes …